- Labrecque N, Cermakian N. Circadian Clocks in the Immune System. Journal of biological rhythms. 2015;30(4):277-90.
- Janeway CA, Travers P, Walport M, Shlomchik MJ. Immunobiology The immune system in health and disease. New York: Garland publishing; 2001.
- Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860-7.
- Chaplin DD. Overview of the Immune Response. Allergy clinical immunology. 2010;125(2):S3-23.
- Hunter P. The inflammation theory of disease
The growing realization that chronic inflammation is crucial in many diseases opens new avenues for treatment. EMBO reports. 2012;13(11):968-70.
- Wild CP. Complementing the Genome with an “Exposome”: The Outstanding Challenge of Environmental Exposure Measurement in Molecular Epidemiology. Cancer epidemiology, biomarkers & preventien. 2005;14(8):1847-50.
- Dennis KK, Jones DP. The Exposome: A New Frontier for Education. The American biology teacher. 2016;78(7):542-8.
- Rodriguez-Segade S, Camiña MF, Carnero A, Lorenzo MJ, Alban A, Quinteiro C, et al. High serum IgA concentrations in patients with diabetes mellitus: agewise distribution and relation to chronic complications. Clin Chem. 1996;42(7):1064-7.
- Rodríguez-Segade S, Camiña MF, Paz JM, Río RD. Abnormal serum immunoglobulin concentrations in patients with diabetes mellitus. Clin Chim Acta. 1991;203(2):135-42.
- Wang X, Li Y, Li H, Gu Y, Song Y, Zhang Q, et al. Relationship of serum immunoglobulin levels to blood pressure and hypertension in an adult population. J Hum Hypertens. 2018;32(3):212-8.
- Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860-7.
- Gonzalez-Quintela A, Alende MR, Gamallo R, Gonzalez-Gil P, Lopez-Ben S, Tome S, et al. Serum immunoglobulins (IgG, IgA, IgM) in chronic hepatitis C. A comparison with non-cirrhotic alcoholic liver disease. Hepatogastroenterology. 2003;50(54):2121-6.
- Gonzalez-Quintela A, Alende R, Gude F, Campos J, Rey J, Meijide LM, et al. Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities. Clin Exp Immunol. 2008;151(1):42-50.
- Walldius G, Malmström H, Jungner I, de Faire U, Lambe M, Van Hemelrijck M, et al. Cohort Profile: The AMORIS cohort. International journal of Epidemiology. 2017;46(4):1103-i.
- Walldius G, Jungner I, Holme I, Aastveit AH, Kolarb W, Steiner E. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. The Lancet. 2001;358(9298):2026-33.
- Holme I, Aastveit AH, Jungner I, Walldius G. Relationships between lipoprotein components and risk of myocardial infarction: age, gender and short versus longer follow‐up periods in the Apolipoprotein MOrtality RISk study (AMORIS). Journal of internal medicine. 2008;264(1):30-8.
- Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G. Relationships between lipoprotein components and risk of ischaemic and haemorrhagic stroke in the Apolipoprotein MOrtality RISk study (AMORIS). Journal of internal medicine. 2009;265(2):275-87.
- Walldius G, Jungner I, Kolar W, Holme I, Steiner E. High cholesterol and triglyceride values in Swedish males and females: increased risk of fatal myocardial infarction. First report from the AMORIS (Apolipoprotein related MOrtality RISk) study. . Blood pressure supplement. 1992;4(1):35-42.
- Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676-82.
- Junger I, Kolar W. S Immunoglobulin A. CALAB; 1994.
- Junger I, Kolar W. S Immunoglobulin G. CALAB; 1994.
- Junger I, Kolar W. S Immunoglobulin M. CALAB; 1994.
- Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G. Inflammatory markers, lipoprotein components and risk of major cardiovascular events in 65,005 men and women in the Apolipoprotein MOrtality RISk study (AMORIS). Atherosclerosis. 2010;213(1):299-305.
- Gaur A, Collins H, Wulaningsih W, Holmberg L, Garmo H, Hammar N, et al. Iron metabolism and risk of cancer in the Swedish AMORIS study. Cancer causes & controll. 2013;24(7):1393-402.
- Santaolalla A, Garmo H, Grigoriadis A, Ghuman S, Hammar N, Jungner I, et al. Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis. BMC Molecular and Cell Biology. 2019;In press.
- Ghoshal A, Garmo H, Arthur R, Hammar N, Jungner I, Malmström H, et al. Serum biomarkers to predict risk of testicular and penile cancer in AMORIS. ecancermedicalscience. 2017;11:762.
Arthur R, Moller H, Garmo H, Holmberg L, Stattin P, Malmstrom H, et al. Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categories. Cancer medicine. 2016;5(6):1307-18.
Walldius G MH, Jungner I, de Faire U, Lambe M, Van Hemelrijck M, Hammar N. The AMORIS cohort – more than 800,000 subjects with information on biomarkers followed for more than 2- years in Swedish national health and quality of care registers. Int J Epidemiology. 2016;In press.
Wulaningsih W, Michaelsson K, Garmo H, Hammar N, Jungner I, Walldius G, et al. Inorganic phosphate and the risk of cancer in the Swedish AMORIS study. BMC Cancer. 2013;13:257.
Wulaningsih W, Michaelsson K, Garmo H, Hammar N, Jungner I, Walldius G, et al. Serum calcium and risk of gastrointestinal cancer in the Swedish AMORIS study. BMC Public Health. 2013;13(1):663.
Gaur A, Collins H, Wulaningsih W, Holmberg L, Garmo H, Hammar N, et al. Iron metabolism and risk of cancer in the Swedish AMORIS study. Cancer Causes Control. 2013;24(7):1393-402.
Melvin JC, Seth D, Holmberg L, Garmo H, Hammar N, Jungner I, et al. Lipid profiles and risk of breast and ovarian cancer in the Swedish AMORIS study. Cancer Epidemiol Biomarkers Prev. 2012;21(8):1381-4.
Van Hemelrijck M, Garmo H, Hammar N, Jungner I, Walldius G, Lambe M, et al. The interplay between lipid profiles, glucose, BMI and risk of kidney cancer in the Swedish AMORIS study. Int J Cancer. 2012;130(9):2118-28.
Wulaningsih W, Garmo H, Holmberg L, Hammar N, Jungner I, Walldius G, et al. Serum Lipids and the Risk of Gastrointestinal Malignancies in the Swedish AMORIS Study. Journal of cancer epidemiology. 2012;2012:792034.
Pepys MB, Hirschfield GM. 2003. The journal of clinical investigation. C-reactive protein: a critical update.;111(12):1805-12.
Quaye IK. Haptoglobin, inflammation and disease. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2008;102:735-42.
Delanghe JR, Langlois MR. Haptoglobin polymorphism and body iron stores. Clinical chemistery and laboratory medicine. 2002;40(3):212-6.
Pillay J, Hietbrink F, Koenderman L, Leenen LP. The systemic inflammatory response induced by trauma is reflected by multiple phenotypes of blood neutrophils. Injury. 2007;38(12):1365-72.
Kelly CC, Lyall H, Petrie JR, Gould GW, Connell JM, Sattar N. Low grade chronic inflammation in women with polycystic ovarian syndrome. The journal of clinical endocrinology & metabolism. 2001;86(6):2453-5.
Greer JB, Greer P, Sandhu BS, Alkaade S, Wilcox CM, Anderson MA, et al. Nutrition and Inflammatory Biomarkers in Chronic Pancreatitis Patients. Nutrition in Clinical Practice. 2018.
Brasky TM, Kabat GC, Ho GYF, Thomson CA, Nicholson WK, Barrington WE, et al. C-reactive protein concentration and risk of selected obesity-related cancers in the Women's Health Initiative. Cancer causes & controll. 2018;29(9):855-62.
Hoshino M, Ohtawa J, Akitsu K. Increased C-reactive protein is associated with airway wall thickness in steroid-naive asthma. Annals of Allergy, Asthma and Immunology. 2014;113(1):37-41.
Shrotriya S, Walsh D, Nowacki AS, Lorton C, Aktas A, Hullihen B, et al. Serum C-reactive protein is an important and powerful prognostic biomarker in most adult solid tumors. PLOS One. 2018;13(8).
Margolis KL, Rodabough RJ, Thomson CA, Lopez AM, McTiernan A. Prospective Study of Leukocyte Count as a Predictor of Incident Breast, Colorectal, Endometrial, and Lung Cancer and Mortality in Postmenopausal Women. Archieves of internal medicine. 2007;167(17):1837-44. Fasano M, Curry S, Terreno E, Galliano M, Fanali G, Narciso P, et al. The extraordinary ligand binding properties of human serum albumin. IUBMB. 2005;57(12):787-96.
Knutson M, Wessling-Resnick M. Iron Metabolism in the Reticuloendothelial System. Critical reviews in biochemistery and molecular biology. 2003;38(1):61-88.
Schroeder HW, Cavacini L. Structure and Function of Immunoglobulins. Allergy clinical immunology. 2010;125(202):41-52.
Arroyo V, García-Martinez R, Salvatella X. Human serum albumin, systemic inflammation, and cirrhosis. J Hepatol. 2014;61(2):396-407.Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Seminars in dialysis. 2004;17(6):432-7.
Castagné R, Delpierre C, Kelly-Irving M, Campanella G, Guida F, Krogh V, et al. A life course approach to explore the biological embedding of socioeconomic position and social mobility through circulating inflammatory markers. Scientific Reports. 2016;6:25170.
Casimir GJA, Duchateau J. Gender Differences in Inflammatory Processes Could Explain Poorer Prognosis for Males. Journal of clinical microbiology. 2011;49(1):478-9.
Ek S. Gender differences in health information behaviour: a Finnish population-based survey. Health promotion international. 2015;30(1):736-45.
Braveman PA, Cubbin C, Egerter S, Williams DR, Pamuk E. Socioeconomic Disparities in Health in the United States: What the Patterns Tell Us. American journal of public health. 2010;100(Suppl 1):S186-S96.
Gordon-Larsen P, Nelson MC, Page P, Popkin BM. Inequality in the built environment underlies key health disparities in physical activity and obesity. Pediatrics. 2006;117(2):417-24.
Stringhini S, Sabia S, Shipley M, Brunner E, Nabi H, Kivimaki M, et al. Association of socioeconomic position with health behaviors and mortality. The Whitehall II study. Jama. 2010;303(12):1159-66.
Cutler DM, Lleras-Muney A. Understanding Differences in Health Behaviors by Education. J Health Econ. 2010;29(1):1-28.
Montecino-Rodriguez E, Berent-Maoz B, Dorshkind K. Causes, consequences, and reversal of immune system aging. The journal of clinical investigation. 2013;123(3):958-65.
Licastro F, Candore G, Lio D, Porcellini E, Colonna-Romano G, Franceschi C, et al. Innate immunity and inflammation in ageing: a key for understanding age-related diseases. Immun Ageing. 2005;2:8-.
Weaving G, Batstone GF, Jones RG. Age and sex variation in serum albumin concentration: an observational study. Ann Clin Biochem. 2016;53(1):106-11.
Gom I, Fukushima H, Shiraki M, Miwa Y, Ando T, Takai K, et al. Relationship between serum albumin level and aging in community-dwelling self-supported elderly population. J Nutr Sci Vitaminol (Tokyo). 2007;53(1):37-42.
Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G. Inflammatory markers, lipoprotein components and risk of major cardiovascular events in 65,005 men and women in the Apolipoprotein MOrtality RISk study (AMORIS). Atherosclerosis. 2010;213(1):299-305.
Wulaningsih W, Michaelsson K, Garmo H, Hammar N, Jungner I, Walldius G, et al. Serum calcium and risk of gastrointestinal cancer in the Swedish AMORIS study. BMC public health. 2013;17(13):663.
Buck L, Smarr MM, Patel CJ. The Exposome Research Paradigm: an Opportunity to Understand the Environmental Basis for Human Health and Disease. Curr Environ Health Rep. 2017;4(1):89-98.